During both IPD and CAPD, acetate or lactate enters the patient, is metabolized, and generates bicarbonate, while bicarbonate is simultaneously being lost into the dialysate. The net balance depends on the pre-dialysis serum bicarbonate of the patient, dialysate buffer concentration, dialysate dwell time and metabolic rate of acetate or lactate (6). Dixon et al (7) studied lactate transfer during IPD using 2L dialysate volume, 1 hour dwell time, and a 45 mEq/L dialysate lactate concentration. Blood lactate and pyruvate rose to 10.4 mg% and 0.56 mg% over 43 hours respectively, and 70 mEq of lactate were absorbed (80%) during a single exchange. 25 to 30 mEq bicarbonate were simultaneously lost into the dialysate per exchange and blood bicarbonate progressively rose. With 5Uhour dialysate flow and zero dwell time, similar results were obtained (8). Rubin et al (9), however, have shown that the clearance of L(+) lactate is significantly greater than D(-), suggesting that the absorption characteristics of the peritoneum are stereospecific. This may have important implications for formulation of more efficient buffering dialysates containing only L(+) lactate or when other organic anions may be substituted.
INTRODUCTION
Ingested foodstuffs are metabolized in the body liberating hydrogen ions, a process called endogenous acid production. Both the rate of cellular metabolism and the quantity of ingested precursors determine the rate of acid production. In dialysis patients as well as individuals with normal renal function this rate approximates 1 mEq/ kg/day. This amount of acid must be excreted or neutralized in order to maintain body acid-base balance and thus a stable blood bicarbonate concentration. In patients on dialysis this is accomplished by body buffering, to a large extent by bone, gastrointestinal loss of acid or gain of base, and buffer input from dialysate (1) . The latter will be the focus of this discussion since it provides the largest contribution of bicarbonate to the body in such patients.
Boen initially described the use of bicarbonate as a buffer in peritoneal dialysate (2) . Lactate was substituted for bicarbonate, however, when calcium carbonate was noted to precipitate during autoclaving. Present day peritoneal dialysis solutions contain acetate (in concentrates for reverse-osmosis machines only) or lactate (all currently available CAPD or CCPD solutions). The metabolism of acetate has been reviewed extensively recently (1, 3) and will not be repeated here.
BUFFER KINETICS DURING DIALYSIS
Intermittant peritoneal dialysis PERITONEAL LACTATE METABOLISM Lactate exists in nature as both D (-) and L (+) stereoisomers. The L (+) form is rapidly metabolized in the body by L+ lactate dehydrogenase, while the D (-) form is metabolized much more slowly. Sodium lactate has a molecular weight of 112 daltons and a pK = 3.9. Lactate is distributed in total body water and diffuses passively across cell membranes. Because of its low pK it IS almost completely dissociated in body fluids. Lactate re~cts with carbonic acid in the body to produce lactic acid and bicarbonate, and thus achieves buffering. Lactate must be converted to pyruvate which in turn may enter the Kreb's cycle, and then is transaminated to alanine or carboxylated to glucose. The former reaction Occurs in all body tissues, while the latter occurs exclusively in liver and kidney. 50% of lactate metabolism ccurs in the liver, while the kidneys account for an additional 30%. Heart and skeletal muscle account for the re~ainder (4). Hyperlactatemia has been reported in p~ntoneal dialysis patients (5) , presumably as a result of failure of adequate lactate metabolism, but this is quite rare.
Kinetic studies of buffer transfer have been performed in CAPD patients (8, 10, 11) . When dialysate lactate is 38.5 mEq/L, 75-95% of the lactate is absorbed and metabolized during a 4-6 hour dwell, and blood lactate level rises to 1.5 mEq/L. Total bicarbonate removal by dialysate is 190-250 mEq/day depending on the serum bicarbonate and number of exchanges performed. Since bicarbonate is more completely equilibrated after a 4hour exchange than lactate, bicarbonate loss into dialysate is a major determinant of acid-base balance. Net base balance, then, is neutral to slightly negative when a 38.5 mEq/L lactate dialysate is utilized. Since acetate is no longer used in CAPD solutions, its kinetics during CAPD will not be discussed here except to say that some evidence of progressive acetate accumulation in CAPD patients using acetate containing solutions has been reported (8) .
Both acetate and lactate containing dialysate have been shown to cause transient vasoconstriction and subsequent vasodilatation of arterioles in a rat cremasteric preparation (12) . No differences in peritoneal clearances of solutes (13, 14) or protein loss (13) has been found between solutions containing one or the other of these anions, however. 0391-3988/600175-02 $ 00.50/ 0 Acid-base homeostasis in peritoneal dialysis patients CHRONIC ACID-BASE CHANGES DURING PERITONEAL DIALYSIS After 8 to 10 hours of IPD with either acetate or lactate containing dialysate, there is a rise in serum bicarbonate and pH (assuming a typical renal failure patient with moderate to severe metabolic acidosis). This is usually accompanied by a modest rise in pC02. The rise in serum bicarbonate is similar in rate to that seen with bicarbonate hemodialysis.
In the United States, and most other parts of the world commercially available dialysate for CAPD contains 35 mEq/L or 40 mEq/L lactate. We recently reviewed the monthly serum bicarbonate levels in our patients on CAPD using the 35 mEq/L containing dialysate. All patients had been on this solution for a minimum of 4 months. Mean serum bicarbonate was 25.2 mEq/L. These values are significantly higher than predialysis plasma bicarbonate levels found in hemodialysis patients dialyzed with acetate or bicarbonate dialysate (1) . Similarly, Nolph et al (15) Because of the high incidence of low serum bicarbonate with this solution, a 40 mEq/L lactate containing dialysate was introduced. As expected, patients treated with this solution have a higher serum bicarbonate. In patients in our program, mean serum bicarbonate with this dialysate was 26.1 ± 0.9 mEq/L, again significantly higher than that seen in hemodialysis patients. Patients were chosen for this solution if mean serum bicarbonate was consistently less than 24 mEq/L (mean = 21.7 ± 0. In summary, the majority of patients on CAPD with a 35 mEq/L lactate containing dialysate will have serum bicarbonate between 20 and 24 mEq/L, higher than that seen predialysis in most patients treated with acetate or bicarbonate hemodialysis. When a 40 mEq/L lactate containing dialysate is used all but a few patients will have serum bicarbonate in the normal range, though some (15-25%) may have elevated serum bicarbonate. It seems reasonable, then, to use the higher lactate containing solution initially and switch to the lower lactate containing solution if serum bicarbonate remains persistantly above 30 mEq/L. Robson et al (11) found no difference in predialysis serum bicarbonate levels between patients on chronic hemodialysis (HC03 = 21.8 mEq/L) and those on IPD (HC03 = 21.0 mEq/L). La Greca et al (6) reported similar findings. It fould appear, therefore, that CAPD does maintain blood bicarbonate concentration at a more normal level than IPD, as well as HD. Whether CAPD also leads to repletion of buffer stores, particularly those of bone, needs to be assessed. In addition, other long term benefits of correction of chronic acid-base disturbances in such patients need to be clarified.
